Patent · US Active

Targeting ABCB5 for cancer therapy

US7928202B2 · kind B2 · utility

16Cited by

24References

24Claims

0Family size

Assignee

The Brigham and Women's Hospital, Inc. · US

Inventors

Markus Frank · Baden-Baden, DE
Natasha Y. Frank · Cambridge, US
Mohamed H. Sayegh · Dedham, US

Key dates

Filing date	Apr 11, 2008
Grant date	Apr 19, 2011
Priority date	—
Expiry date	Apr 28, 2028

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/705
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to methods for treating a subject by manipulating ABCB5 on a cell as well as related products. The methods include methods of treating cancer using ABCB5 binding molecules such as antibodies and fragments thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.